Research Centre - Biocon
Biocon Biologics Limited | ISPE | International Society for Pharmaceutical Engineering
Biocon Q4 results show Consolidated revenue up by 21% - The Statesman
Exclusive | Biocon, Mylan Biosimilar Deal in Last Leg; Serum Institute to Buy Additional Stake of $500 Million in Biocon Biologics: Sources
Biocon's pre-tax profit rises 9% to Rs 315 crore in Oct-Dec quarter | Business Standard News
Biocon - 72 new faces joined us in February. Many... | Facebook
Biocon Biologics, Serum Institute Life Sciences enter strategic alliance
Syngene International: Biocon sells 5.4% stake in arm Syngene International - The Economic Times
BIOCON Stock Price and Chart — NSE:BIOCON — TradingView
Meet Biocon Biologics: A 2021 Facility of the Year Honorable Mention Award Winner | Pharmaceutical Engineering
Biocon Biologics to Acquire Viatris' Biosimilars Assets for up to USD 3.335 billion in Stock and Cash
Biocon announces merger of its arm with Serum Institute subsidiary - BusinessToday
Biocon Campus - Biocon
Biocon in pact with Japan's Yoshindo to commercialise two biosimilar assets | Mint
True North to acquire 2.4% stake in Biocon Biologics at a valuation of $3 billion | Mint
Research Centre - Biocon
Biocon Biologics Receives USD 150 Million Capital Injection from Goldman Sachs - Biocon
Biocon Biologics enters licensing agreement with Yoshindo of Japan - The Hindu BusinessLine
Fortune India: Business News, Strategy, Finance and Corporate Insight
Biocon sells 5.4% stake in its research arm Syngene International - Hindustan Times
Biocon Biologics' antibody drug unit in Bengaluru gets EU GMP certificate | Business Standard News
Biocon - Wikipedia
Biocon subsidiary acquires Viatris pharma for $3 billion | Mint
Biocon biosimilar plant criticized again by the FDA | Fierce Pharma
Meet Biocon Biologics: A 2021 Facility of the Year Honorable Mention Award Winner | Pharmaceutical Engineering
